Two patients have been successfully treated with Millipede’s latest-generation delivery system that incorporates a fully integrated intracardiac echocardiography (ICE) catheter. The catheter was designed to enhance the precise delivery and accurate placement of the company’s IRIS annuloplasty ring implant.
A press release states that the two patients, both of whom had functional regurgitation, were discharged from the hospital on the following day. It adds that they, and all previously implanted Millipede patients, continue to do well on their latest follow ups.
According to the press release, the IRIS annuloplasty ring—delivered via a transcatheter-transseptal delivery system—follows the standard surgical approach to repair and reduce the size of a dilated mitral annulus. The IRIS device is a complete ring designed to be used as a standalone device, or in combination with other technologies in patients with severe mitral regurgitation. The system is also capable of being used to treat severe tricuspid regurgitation.
Interventional cardiologist Jason Rogers (Sacramento, USA), comments: “This latest generation Millipede IRIS has many improvements and now with the integrated ICE imaging catheter, we are able to implant the semi-rigid adjustable ring easily and precisely with total procedural times under two hours.”
Randy Lashinski, Millipede’s president and CEO, says: “Our team is very excited to see the advancement of the delivery system and implant now with integrated ICE being used in patients with functional mitral regurgitation.”
